Tema Oncology ETF CANC
39.52 USD -0.70 (-1.74%)
Regular-session close
39.56 +0.04 +0.11%
After hours · Nov 17, 4:00 PM ET
39.22 Day range 40.19
33.58 52-week range 45.24
- YTD
- +13.82%
- 1 year
- +17.68%
News
zacks.com Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough Merck-Moderna's melanoma vaccine success could boost immunotherapy growth, putting healthcare ETFs in the spotlight.
zacks.com Biotech ETF (CANC) Hits New 52-Week High CANC hits a 52-week high as strong oncology developments and positive momentum fuel the biotech ETF's rally.
businesswire.com Tema ETFs Exceeds $5bn in AUM After Three Years NEW YORK--(BUSINESS WIRE)--Tema ETFs (“Tema”), a leader in institutional-quality and actively managed exchange-traded funds, has surpassed $5 billion in assets under management (AUM) three years…
businesswire.com Tema ETFs Surpasses $2 Billion in AUM in Under Three Years NEW YORK--(BUSINESS WIRE)--Tema ETFs (“Tema”), a leader in institutional-quality and actively managed exchange-traded funds, today announced that the firm has surpassed $2 billion in assets under…
seekingalpha.com CANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting Stocks Tema Oncology ETF receives a Hold rating due to inconsistent returns but it does currently have a high Quant Ranking in the healthcare subclass. CANC offers diversified exposure across market caps…
businesswire.com Tema Appoints ETF Industry Leader Steve Munroe as President NEW YORK--(BUSINESS WIRE)--Tema ETFs (“Tema”), a leader in institutional-quality and actively managed exchange-traded funds, today announced the appointment of Steve Munroe as President. In this…
defenseworld.net Thrivent Financial for Lutherans Decreases Stake in Tema Oncology ETF $CANC Thrivent Financial for Lutherans cut its holdings in shares of Tema Oncology ETF (NASDAQ: CANC) by 84.6% in the undefined quarter, according to its most recent disclosure with the Securities and…
businesswire.com Tema's Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance NEW YORK--(BUSINESS WIRE)--Tema ETFs (“Tema”), the New York-based manager of innovative exchange-traded funds (ETFs), is pleased to announce the Tema Oncology ETF (“CANC”) has surpassed $100m in…
zacks.com Be Thankful to These ETFs This Year Be thankful for this year's resilient ETFs -- BWET, LITP, PINK and CANC -- which shined despite volatility, tariffs, AI worries and Fed shifts.
etftrends.com Disruptive Theme of the Week – Breakthroughs in Medicine Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical…
zacks.com Inside Tema ETFs' New Oncology ETF (CANC) Oncology treatment has witnessed remarkable progress due to the relentless efforts of pharmaceutical companies in recent times.
etftrends.com This Week in ETFs: 2 New Funds Launch From Tema The U.S. ETF industry saw a major slowdown in ETF launches during the week ending Aug. 18 as the summer slump continued. Only six new ETFs launched, while issuers announced only one new closure.
